Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis
Status:
Completed
Trial end date:
2018-09-02
Target enrollment:
Participant gender:
Summary
Primary Objective:
To assess the efficacy of the new hard boiled Ambroxol lozenges 20 mg for the relief of sore
throat pain in patients with acute pharyngitis.
Secondary Objective:
To assess the safety of the new hard boiled Ambroxol lozenges 20 mg in patients with acute
pharyngitis.